Pharmaceutical Executive July 16, 2024
In this part of his Pharmaceutical Executive video interview, Fabrice Chouraqui, CEO of Cellarity, speaks about the broader implications of Cellarity’s approach for the drug discovery field.
Beyond the potential for transformative treatments, what are the broader implications of Cellarity’s approach for the drug discovery field? Could it potentially lead to faster development times or reduced costs?
The cell is a much better proxy for disease than just a single molecular target, and as such, we have developed a platform to yield much higher level of clinical transability, which is one of the major limitations of the current drug discovery process. So, with this obviously we expect to decrease the rate of failure and so we can obviously decrease the...
Today's Sponsors
Today's Sponsor